Oura revenue and valuation
Specter estimates Oura's annual revenue at $1.08B to $2.01B and its valuation at $11.6B to $15.3B. The company last reported $1.4B revenue in June 2026 and was priced at $11B in October 2025.
- Estimated revenue
- $1.08B–$2.01B
- Estimated valuation
- $11.6B–$15.3B
- Reported revenue
- $1.4B
- Total funding
- $1.5B
- Founded
- 2013
- Headquarters
- San Francisco, United States
- Employees
- 1,650
Oura revenue
Oura grew from $500M revenue in December 2024 to $1.4B in June 2026. Specter's model puts current revenue between $1.08B and $2.01B, anchored to three reported figures.
Monthly data
| Month | Specter estimate | Low | High | Reported revenue |
|---|---|---|---|---|
| $1.47B | $1.08B | $2.01B | ||
| $1.42B | $1.05B | $1.92B | ||
| $1.42B | $1.1B | $1.83B | ||
| $1.39B | $1.12B | $1.73B | ||
| $1.4B | $1.16B | $1.68B | $1.4B | |
| $1.32B | $960M | $1.82B | ||
| $1.25B | $960M | $1.63B | ||
| $1.18B | $920M | $1.52B | ||
| $1.12B | $860M | $1.46B | ||
| $1.06B | $840M | $1.33B | ||
| $1B | $830M | $1.2B | ||
| $940M | $520M | $1.72B | ||
| $890M | $570M | $1.4B | ||
| $840M | $540M | $1.32B | ||
| $790M | $480M | $1.32B | ||
| $750M | $480M | $1.18B | ||
| $710M | $480M | $1.05B | ||
| $670M | $460M | $970M | ||
| $630M | $450M | $890M | ||
| $590M | $440M | $800M | ||
| $560M | $440M | $720M | ||
| $530M | $430M | $660M | ||
| $500M | $420M | $600M | $500M | |
| $250M | $114M | $380M | ||
| $190M | $80M | $300M | ||
| $197M | $84M | $310M | ||
| $183M | $81M | $290M | ||
| $176M | $86M | $270M | ||
| $171M | $85M | $260M |
| Date | Reported revenue | Source |
|---|---|---|
| $1.4B | ||
| $1.61B | ||
| $500M |
Oura valuation
Oura's valuation rose from $800M at its Series C in May 2021 to $11B at its Series E in October 2025. Specter's live estimate sits between $11.6B and $15.3B.
Monthly data
| Month | Specter estimate | Low | High | Reported valuation |
|---|---|---|---|---|
| $13.3B | $11.6B | $15.3B | ||
| $10.9B | $7.53B | $15.8B | ||
| $11B | $7.74B | $15.7B | ||
| $11.1B | $8.66B | $14.2B | ||
| $11.2B | $7.94B | $15.9B | ||
| $10.8B | $7.9B | $14.7B | ||
| $10.7B | $8.16B | $14B | ||
| $10.8B | $8.45B | $13.8B | ||
| $10.9B | $8.82B | $13.5B | ||
| $11B | $9.15B | $13.2B | $11B (press) | |
| $11B | $8.73B | $13.9B | ||
| $11B | $8.96B | $13.5B | ||
| $11B | $9.15B | $13.2B | $11B (round) | |
| $10.9B | $9.11B | $13.2B | $10.9B (press) | |
| $10.3B | $7.84B | $13.5B | ||
| $9.65B | $7.41B | $12.6B | ||
| $9.06B | $7.06B | $11.6B | ||
| $8.5B | $6.74B | $10.7B | ||
| $7.98B | $6.42B | $9.92B | ||
| $7.49B | $6.1B | $9.21B | ||
| $7.04B | $5.79B | $8.55B | ||
| $6.6B | $5.47B | $7.97B | ||
| $6.2B | $5.16B | $7.45B | $6.2B (press) | |
| $5.2B | $4.33B | $6.25B | $5.2B (round) | |
| $5.08B | $2.4B | $10.7B | ||
| $4.95B | $2.55B | $9.62B | ||
| $4.83B | $2.29B | $10.2B | ||
| $4.72B | $2.75B | $8.1B | ||
| $4.61B | $2.72B | $7.81B |
Oura funding rounds
| Date | Round | Raised | Post-money valuation | Lead investors |
|---|---|---|---|---|
| Corporate round | Undisclosed | Undisclosed | Eli Lilly | |
| Series E | $900M | $11B | Fidelity | |
| Debt financing | $250M | Undisclosed | Undisclosed | |
| Series D | $200M | $5.2B | Fidelity, Dexcom | |
| Venture round | Undisclosed | $2.55B | Undisclosed | |
| Series C | $100M | $800M | Elysian Park Ventures, TCG | |
| Series B | $28M | Undisclosed | Forerunner, Gradient | |
| Series A | $6M | Undisclosed | DFO Management | |
| Series A | $6.16M | Undisclosed | Tesi, Bold Capital Partners | |
| Series A | $5.62M | Undisclosed | Jaan Tallinn, Harpreet Singh Rai, Lateralus Holdings | |
| Seed | $2.3M | Undisclosed | Lifeline Ventures |
Oura competitors
The smart ring market splits between general wellness tracking and clinical-grade health diagnostics.
| Company | Revenue | Valuation |
|---|---|---|
| $1.08B–$2.01B | $11.6B–$15.3B | |
| $111M–$175M | $330M–$480M | |
| $3.4M–$16M | $20M–$121M | |
| $5.6M–$19M | $53M–$91M | |
| $1.1M–$5.3M | $3.7M–$18M |
Oura revenue and valuation FAQ
What is Oura's revenue?
Specter estimates Oura's annual revenue at $1.08B to $2.01B as of October 2026. Oura last reported $1.4B revenue in June 2026, up from $500M in December 2024.
What is Oura's valuation?
Oura's latest post-money valuation is $11B, from an October 2025 Series E. Specter's live estimate is $11.6B to $15.3B.
What is Oura's revenue multiple?
Oura is valued at about 7.9× revenue, based on its $11B October 2025 valuation and $1.4B last reported revenue. That works out to roughly $848K of revenue per employee.
How much funding has Oura raised?
$1.5B across 11 rounds, from a $2.3M Seed in November 2015 to a corporate round in July 2026.
Who invested in Oura?
64 investors, including Dexcom, Eli Lilly, Elysian Park Ventures, Fidelity, Forerunner and TCG.
Who are Oura's competitors?
Ultrahuman, RingConn, Gabit and Circular. Specter ranks 30 competitors for Oura.